Evidence map›Paper›PMID 37342418›Full record

ArticleFunction (Oxford, England)2023

Endogenous Amyloid-formed Ca

Shuangtao Li, Xiaoyu Ji, Ming Gao, Bing Huang, Shuang Peng, Jie Wu

Open access · goldAbstract read
In one paragraph

Article in Function (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Shuangtao LiBrain Function and Disease Laboratory, Shantou University Medical College, Shantou, Guangdong 515041, China.
Xiaoyu JiBrain Function and Disease Laboratory, Shantou University Medical College, Shantou, Guangdong 515041, China.
Ming GaoDepartment of Neurobiology, Barrow Neurological Institute and St. Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA.
Bing HuangBrain Function and Disease Laboratory, Shantou University Medical College, Shantou, Guangdong 515041, China.
Shuang PengSchool of Sport and Health Sciences, Guangzhou Sport University, Guangzhou 510500, China.ORCID 0000-0002-0163-9047
Jie WuBrain Function and Disease Laboratory, Shantou University Medical College, Shantou, Guangdong 515041, China.
Shantou University · CNBarrow Neurological Institute · USGuangzhou Sport University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD), the leading cause of dementia, is characterized by the accumulation of beta-amyloid peptides (Aβ). However, whether Aβ itself is a key toxic agent in AD pathogenesis and the precise mechanism of Aβ-elicited neurotoxicity are still debated. Emerging evidence demonstrates that the Aβ channel/pore hypothesis could explain Aβ toxicity, because Aβ oligomers are able to disrupt membranes and cause edge-conductivity pores that may disrupt cell Ca

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsDisease Models, AnimalHomeostasisMiceMice, TransgenicAmyloid beta-Peptides

Identifiers

PMID37342418
PMCPMC10278988
OpenAlexW4378532283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.